Members of the Heart Rhythm Society visited 35 congressional offices on Capitol Hill to raise visibility and support for two proposals: the “Medicare Program Integrity Improvement and Education Act” and the “Teaching Children to Save Lives Act.” HRS is advocating for the support of these two bills because both intend to deliver outcomes aligned with the Society’s mission to improve the care of patients by advancing research, education and optimal health care policies and standards.
Showing all archived press releases starting with 2014. Back
A new study shows young adults with congenital heart disease (CHD) also living with an implantable cardioverter- defibrillator (ICD) experience a high level of shock-related anxiety. The multicenter study, published in the June edition of HeartRhythm, the official journal of the Heart Rhythm Society, is the first to discover that shock-related anxiety is associated with sexual dysfunction in young adults and calls on healthcare providers to address these issues to improve the quality of life for patients.
Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week. Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Medicine and Professor of Cardiology at the Johns Hopkins University of Medicine in Baltimore, Maryland.
DENVER – Social media may hold the key to improving outcomes of sudden cardiac arrest (SCA) emergencies, which claim more than 350,000 lives in the United States (U.S.) each year. A new initiative to build a geolocated automated external defibrillator (AED) database through crowdsourcing may be a low cost, high impact concept to help the public find an AED in an emergency. Findings from the pilot study were revealed today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
DENVER– New research presented at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, continues to show promising results for Focal Impulse and Rotor Modulation (FIRM) guided ablation in patients with atrial fibrillation (AF). The novel diagnostic real-time mapping system helps target ablation therapy to patient-specific drivers of AF rather than to anatomical targets, which can improve patient outcomes.
DENVER – While certain well-known health conditions including obesity, high blood pressure and cholesterol are often linked to heart disease, a new study is the first to show a connection between sex hormones and the risk of sudden cardiac death (SCD). The findings could help improve clinical predictors of sudden cardiac arrest (SCA) in both men and women and were presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
DENVER – Wearable cardioverter defibrillators (WCD) can be an effective therapy option for patients with a transient or undefined arrhythmic risk, according to the WEARIT-II Registry, the largest prospective study to track patients with the device in a real world setting. The new findings show that WCDs can serve as a bridging therapy and help avoid unnecessary permanent implantation of defibrillators in patients who ultimately may not need them. Findings were released today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
The Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA) and Asia Pacific Heart Rhythm Society (APHRS), release the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes. The expert consensus statement presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions, provides the first comprehensive statement of recommendations on the proper diagnosis and management of patients with inherited primary arrhythmia syndromes.
The first patient tests of a new leadless pacemaker show that the device can deliver the same life-saving therapy as a traditional single-chamber pacemaker without potential lead-related complications. The findings are part of the LEADLESS trial and were released today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
DENVER – A new study shows that iPad 2s can cause magnetic interference with cardiac rhythm devices and suspend life-saving anti-tachycardia therapy in patients. The research was conducted by a 14 year-old high school freshman and presented today at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.